Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (AU2016248050) Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues

Office : Australia
Application Number: 2016248050 Application Date: 13.04.2016
Publication Number: 2016248050 Publication Date: 20.10.2016
Publication Kind : A1
Prior PCT appl.: Application Number:US2016027312 ; Publication Number: Click to see the data
IPC:
C12Q 1/68
A61K 35/74
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
Q
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1
Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
68
involving nucleic acids
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35
Medicinal preparations containing material or reaction products thereof with undetermined constitution
66
Materials from micro-organisms
74
Bacteria
Applicants: Ubiome, Inc.
Inventors:
Agents: Clark Intellectual Property Pty Ltd
Priority Data: 62/146,810 13.04.2015 US
62/146,833 13.04.2015 US
62/146,852 13.04.2015 US
62/147,058 14.04.2015 US
62/147,077 14.04.2015 US
62/147,124 14.04.2015 US
62/147,315 14.04.2015 US
62/147,337 14.04.2015 US
Title: (EN) Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues
Abstract: front page image
(EN) A method for at least one of characterizing, diagnosing and treating a neurological health issue in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the neurological health issue based upon features extracted from at least one of the microbiome composition dataset and the microbiome functional diversity dataset; based upon the characterization, generating a therapy model configured to correct the neurological health issue; and at an output device associated with the subject, promoting a therapy to the subject based upon the characterization and the therapy model.